Leni and Peter W. May Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Pharmacology, Physiology and Biophysics, Chobanian and Avedisian School of Medicine at Boston University, Boston, MA 02118, USA.
Int J Mol Sci. 2024 Feb 1;25(3):1762. doi: 10.3390/ijms25031762.
Chronic painful intervertebral disc (IVD) degeneration (i.e., discogenic pain) is a major source of global disability needing improved knowledge on multiple-tissue interactions and how they progress in order improve treatment strategies. This study used an in vivo rat annulus fibrosus (AF) injury-driven discogenic pain model to investigate the acute and chronic changes in IVD degeneration and spinal inflammation, as well as sensitization, inflammation, and remodeling in dorsal root ganglion (DRG) and spinal cord (SC) dorsal horn. AF injury induced moderate IVD degeneration with acute and broad spinal inflammation that progressed to DRG to SC changes within days and weeks, respectively. Specifically, AF injury elevated macrophages in the spine (CD68) and DRGs (Iba1) that peaked at 3 days post-injury, and increased microglia (Iba1) in SC that peaked at 2 weeks post-injury. AF injury also triggered glial responses with elevated GFAP in DRGs and SC at least 8 weeks post-injury. Spinal CD68 and SC neuropeptide Substance P both remained elevated at 8 weeks, suggesting that slow and incomplete IVD healing provides a chronic source of inflammation with continued SC sensitization. We conclude that AF injury-driven IVD degeneration induces acute spinal, DRG, and SC inflammatory crosstalk with sustained glial responses in both DRGs and SC, leading to chronic SC sensitization and neural plasticity. The known association of these markers with neuropathic pain suggests that therapeutic strategies for discogenic pain need to target both spinal and nervous systems, with early strategies managing acute inflammatory processes, and late strategies targeting chronic IVD inflammation, SC sensitization, and remodeling.
慢性疼痛性椎间盘(IVD)退变(即椎间盘源性疼痛)是全球残疾的主要来源,需要更好地了解多种组织相互作用及其进展方式,以改善治疗策略。本研究使用体内大鼠纤维环(AF)损伤驱动的椎间盘源性疼痛模型,研究了 IVD 退变和脊柱炎症的急性和慢性变化,以及背根神经节(DRG)和脊髓(SC)背角中的感觉过敏、炎症和重塑。AF 损伤引起的 IVD 退变程度中等,伴有急性和广泛的脊柱炎症,分别在数天和数周内进展为 DRG 至 SC 变化。具体而言,AF 损伤使脊柱(CD68)和 DRG(Iba1)中的巨噬细胞(CD68)和 DRG(Iba1)升高,在损伤后 3 天达到峰值,而 SC 中的小胶质细胞(Iba1)在损伤后 2 周达到峰值。AF 损伤还引发了胶质细胞反应,导致 DRG 和 SC 中的 GFAP 升高,至少在损伤后 8 周升高。脊柱 CD68 和 SC 神经肽 P 物质均在 8 周时升高,表明 IVD 愈合缓慢且不完全,为炎症提供了慢性来源,并持续导致 SC 致敏。我们得出结论,AF 损伤驱动的 IVD 退变引起急性脊柱、DRG 和 SC 炎症串扰,并在 DRG 和 SC 中持续存在胶质细胞反应,导致慢性 SC 致敏和神经可塑性。这些标志物与神经病理性疼痛的已知关联表明,椎间盘源性疼痛的治疗策略需要靶向脊柱和神经系统,早期策略管理急性炎症过程,晚期策略靶向慢性 IVD 炎症、SC 致敏和重塑。